Less Ads, More Data, More Tools Register for FREE

Pin to quick picksS & U Regulatory News (SUS)

Share Price Information for S & U (SUS)

Share Price is delayed by 15 minutes
Get Live Data
1,915.00    -10.00 (-0.52%)
Bid:
1,910.00
Ask:
1,945.00
Spread: 35.00 (1.832%)
Market Cap: £232.69m
SUS Live PriceLast checked at - London Stock Exchange

Intraday S & U Share Chart

Interim Management Statement

21 May 2015 07:00

RNS Number : 8442N
S & U PLC
21 May 2015
 

 

21st May 2015

 

S&U plc ("S&U" or "the Group)

Interim Management Statement

 

S&U, Britain's foremost specialist motor finance and home credit provider, issues an IMS for the period from the 2nd February 2015 to the 20th May 2015 ahead of its AGM being held later today.

Group trading continues to be satisfactory. Advantage Finance, our motor finance business, maintains record debt quality and anticipates meeting transaction targets this year. Whilst sales in our home credit business have reflected a more cautious climate prior to the General Election and full Financial Conduct Authority ("FCA") authorisation, weekly collections remain strong on conservative underwriting standards.

Cash generation remains good in both businesses and overall Group profitability is comfortably ahead of last year.

Funding and Capital

Increased cash generation from our home credit business has partly off-set a lower year on year investment in our maturing motor finance business. Hence current head room remains substantial, and allows the continued expansion of our motor finance business to meet an expected increase in summer and autumn demand particularly following the General Election.

This strong treasury position has been buttressed during the period by the confirmation of further medium term facilities from HSBC, our principal bankers. Nevertheless, to achieve our objective of diversifying long-term funding, we are in constructive and continuing negotiations with both the Prudential Regulatory Authority ("PRA") and Financial Conduct Authority ""("FCA") with a view to obtaining a Deposit Taking Licence.

Regulatory Environment

Our Home Credit business has been preparing its application for full FCA authorisation. We anticipate that the FCA will adopt a proportionate and co-operative regulatory approach and that the preparations made for authorisation will further improve the quality of our customer service and the operational efficiency of our representatives. Advantage Finance will similarly embark on an application for full authorisation early next year and looks forward to continuing a positive and pragmatic relationship with the Regulator.

 

Commenting on Group trading and outlook, Anthony Coombs, S&U Chairman, said:

"Although forthcoming regulatory changes and a pause in consumer appetite pending the General Election have made sales less buoyant than the recent past, Group collections, debt quality and our treasury position remain very strong. We look forward to yet another successful year."

 

For further information, please contact:

S&U plc

www.suplc.co.uk 

Anthony Coombs, Chairman

 

0121 705 7777

Broker and Financial Adviser

Chris Hardie

 

Arden Partners

0207 614 5917

 

Media and Investor Relations

Will Swan

 

Smithfield020 7360 4900

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSFMGZKVGLGKZM
Date   Source Headline
25th May 20237:00 amRNSAGM Statement and Trading Update
25th Apr 20232:00 pmRNSAnnual Report and Accounts
25th Apr 202311:48 amRNSDirector/PDMR Shareholding
20th Apr 20237:00 amRNSMello Investor Presentation
6th Apr 20234:08 pmRNSAnnouncement of Annual Report and Accounts
28th Mar 20234:35 pmRNSPrice Monitoring Extension
28th Mar 20237:00 amRNSPreliminary Results
23rd Mar 20234:35 pmRNSPrice Monitoring Extension
28th Feb 20237:00 amRNSResults Presentations for Analysts and Investors
14th Feb 20232:00 pmRNSAppointment of Executive Director
9th Feb 20237:00 amRNSTrading Statement and Notice of Results
8th Dec 20227:00 amRNSTrading Statement
27th Sep 20227:00 amRNSInterim Results
30th Aug 20227:00 amRNSResults Presentations for Analysts and Investors
18th Aug 20224:36 pmRNSPrice Monitoring Extension
10th Aug 20227:00 amRNSTrading Update and Notice of Results
3rd Aug 20224:40 pmRNSSecond Price Monitoring Extn
3rd Aug 20224:35 pmRNSPrice Monitoring Extension
8th Jul 20225:06 pmRNSDirector/PDMR and PCA Shareholding
1st Jun 20227:00 amRNSTotal Voting Rights
26th May 202212:33 pmRNSResult of AGM
26th May 20227:00 amRNSAGM Statement and Trading Update
23rd May 20227:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
18th May 202211:30 amRNSOptions, Director/PDMR Shareholding, Voting Rights
13th May 20224:33 pmRNSDirector/PDMR Shareholding
5th May 20221:53 pmRNSDirector/PDMR Shareholding, Options, Voting Rights
26th Apr 20222:00 pmRNSAnnual Report and Accounts
4th Apr 20227:00 amEQSEdison Investment Research Limited: S&U (SUS): Seeing recovery and adapting to grow
4th Apr 20227:00 amRNSAnnual Report and Accounts
29th Mar 20227:00 amRNSPreliminary Results
9th Mar 20227:00 amRNSResults Presentations for Analysts and Investors
10th Feb 20227:00 amRNSTrading Statement and Notice of Results
17th Jan 20222:39 pmRNSAppointment of non-executive director
17th Jan 20222:33 pmRNSDirector/PDMR Shareholding
9th Dec 20217:00 amRNSTrading Statement
7th Dec 20217:00 amRNSBlock Listing Application
23rd Nov 20217:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
29th Oct 20219:46 amRNSDirector/PDMR Shareholding
6th Oct 20217:00 amRNSDirector/PDMR Shareholding
28th Sep 20217:00 amRNSInterim Results
22nd Sep 20217:00 amRNSInvestor Presentation
10th Aug 20217:00 amRNSTrading Update and Notice of Results
23rd Jul 20214:50 pmRNSDirector/PDMR Shareholding
30th Jun 20214:02 pmRNSDirector/PDMR Shareholding
24th May 20217:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
20th May 202110:00 amRNSResult of AGM
20th May 20217:00 amRNSAGM Statement and Trading Update
23rd Apr 20211:00 pmRNSAnnual Report and Accounts
16th Apr 20215:37 pmRNSDirector/PDMR Shareholding and Total Voting Rights
14th Apr 20219:54 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.